Plain-English translation of NCT07091942 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a retrospective study — meaning researchers look back at medical records — of people with advanced liver cancer who were treated with atezolizumab and bevacizumab. The study asks an important question: when this medication shrinks a tumor enough that surgery becomes possible, does having that surgery lead to better long-term outcomes than staying on the medication alone?
About 30% of patients see their tumors shrink significantly with this medication combination. Some shrink enough to be surgically removed, but doctors don't yet know if those patients live longer or stay cancer-free longer compared to patients who respond well but don't have surgery.
This is a records-based study, so you would not attend visits or receive new treatments. Instead, researchers from hospitals worldwide would review your existing medical records to gather information about your cancer diagnosis, how you responded to treatment, any surgery you had, and your long-term health outcomes. Data collection continues through March 2025.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
Taiwan